Clinical FeaturesGastroenterology

Association of Helicobacter Pylori With Development of Peptic Ulcer Disease Among Cirrhotic Patients: An Evidence From Population-Based Study

Written by Tsu Jung Yang, Krithika Dhanasekar, Renu Bhandari, Divya Muraleedharan, Swathy S. Chirindoth, Harpreet Kaur, Ruchir Goswami, Prakash Maiyani, Maheshkumar Desai, Dharmeshkumar V. Moradiya, Hiteshkumar Devani, Achint A. Patel


There is evidence to suggest higher bleeding complications, delayed healing, and a greater ulcer recurrence rate in patients with liver cirrhosis compared with the general population. 1 Chronic liver disease and its complications are major health problems. In a study by Kamalaporn et al., the prevalence of peptic ulcer disease (PUD) in cirrhotic patients reported by endoscopy screening studies was approximately 5% to 20% when compared with 2% to 4% in the general population. 2

The reasons for the increased ulcer rate in cirrhotic patients are unknown. Oxidative stress that causes gastric tissue damage in cirrhosis may be one of the components causing gastric lesions and hemorrhage. 3 Studies have shown that PUD has been the cause of upper GI bleeding in almost 10% of cirrhotic patients 4 An episode of upper GI bleeding can actually worsen the prognosis of cirrhotic patients. 5 Eradication therapy may be beneficial because it diminishes the risk of recurrent PUD. 6

Helicobacter pylori (H. pylori) are a non-invasive gram-negative bacterium that colonizes gastric mucosa and causes PUD. 7 Although several virulence factors of H. pylori have been identified but the precise mechanism by which it causes mucosal damage is yet to be understood. 3,8 H. pylori play an important role in causing PUD in the general population. However, its role in cirrhosis remains obscure.

There are various studies on H. pylori associated with PUD in cirrhotic patients, but the results have been non-conclusive regarding the association of H. pylori with PUD in patients with liver cirrhosis. 9-11 Therefore, there is a need for further study in this area. In the present study, we aim to find an association of H. pylori with PUD in patients with liver cirrhosis by using the largest nationally representative database.


Data sourcesWe derived a study cohort from the National (Nationwide) Inpatient Sample (NIS) of the Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality (AHRQ). NIS is one of the largest all-payer publicly available databases on inpatient discharges from U.S. hospitals maintained by the AHRQ.

The NIS approximates a 20-percent stratified sample of discharges from U.S. community hospitals, excluding rehabilitation, and long-term acute care hospitals, and contains more than 7 million hospitalizations annually. 12 With the established weights in NIS, this data could be weighted to represent the standardized U.S. population and obtain national estimates with high accuracy. 13

The NIS contains data from 1000 hospitals and includes information on about eight million hospitalizations each year. The database represents a random, 20% stratified sample of all inpatient discharges from 46 states (representing >97% of discharges from all the US hospitals).

Variable “DISCWT” (Discharge-level weight) is provided by HCUP to generate national estimates. 13 The sample sizes and the proportions presented in this study are the weighted estimates obtained by applying the discharge level weights. Each individual hospitalization in this database is de-identified and maintained as a unique entry with one primary discharge diagnosis.

Study population and design

We used data of 2017 for analysis purposes based on complete data availability during this time period. We restricted analyses to only adult hospitalizations. We identified various diagnoses of interest by using the International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) diagnosis codes.

Hospitalization with Peptic Ulcer Disease (PUD) was identified with the presence of ICD-10-CM codes of K25xx-K28xx in any diagnostic field that is available in the dataset. These codes have been used by previously published articles from administrative databases such as NIS [14]. Similarly, cirrhosis by previously validated ICD-10-CM diagnosis codes K74.60 and H. pylori infection by using B96.81. 15

Definition of variables

We extracted demographics, hospital-level characteristics (geographical region, size, and teaching status), and patientlevel characteristics as supplied as part of NIS. We estimated comorbidities using Elixhauser comorbidity software, which is also supplied by HCUP tools and software [16]. Specific concurrent medical conditions and procedures of interest were identified by ICD-10-CM diagnosis and procedure codes.

End point

The primary objective of thestudy was to estimate the association of H. pylori to PUD in cirrhotic patients. The secondary objective was to determine the baseline characteristics and factors associated with H. pylori infections in patients with PUD and concurrent cirrhosis.

Statistical analysis

Descriptive statistics were used to compare and present the baseline population. Categorical variables were compared with the chi-square test, and continuous variables were compared with Student’s t-test or Wilcoxon rank-sum test based on the distribution of data variables. To estimate the association of H. pylori to PUD in cirrhotic patients, we formulated logistic regression models and adjusted them for potential confounders.

First, we formulated a regression model by inserting hospitalization due to PUD as an outcome variable and the presence of cirrhosis and H. pylori as independent variables. Then we inserted interaction between cirrhosis and H. pylori in a regression model in order to estimate the association of H. pylori to PUD in cirrhotic patients. In a final regression model to calculate adjusted estimates, we included patient demographics, comorbidities, and other concurrent factors such as NSAIDs, steroids use, alcoholism, and smoking.

We utilized Statistical Analysis System (SAS) 9.3 (SAS Institute, Cary, NC, USA) for all analyses and included designated weight values to produce nationally representative estimates. 13 For regression models, we used survey procedures to account for the inherent survey design of NIS to produce more robust estimates. 17 We considered a two-tailed p-value <0.05 as statistically significant.


Association of H. pylori with PUD in cirrhotic patients

In 2017, there were 30,421,825 adult hospitalizations in the USA, out of which 956,020 had cirrhosis, and 431,825 had PUD present in their diagnoses. Prevalence of H. pylori was 2.2% in cirrhotic patients with PUD and 2.8% in non-cirrhotic patients with PUD. In regression analysis, H. pylori was associated with PUD in cirrhotic patients (OR 15.1; 95% CI: 13.9-16.4; p <0.001) and non-cirrhotic patients (OR 48.8; 95% CI: 47.5-50.1; p <0.001).

Baseline characteristics of patients with PUD and concurrent cirrhosis by H. pylori status Demographic characteristics of patients admitted due to PUD with underlying cirrhosis and having H. pylori were more likely to be 50-64 years old (49.4% vs 44.1%; p <0.0001), male (63.4% vs 59.9%; p <0.0413), African American (16.3% vs 10.6%; p <0.0001), and Hispanic (26.2% vs 14.9%; p <0.0001). H. pylori are more likely to be associated with complicated PUD hospitalizations (51.2% vs 44.2%; p <0.0067).

Alcoholism and smoking were more common in the H. pylori group compared to those without H. pylori infection (43.6% vs 35.8%; p <0.0001 and 33.7% vs 24.8% p <0.0001, respectively). Moreover, low median household income (39% vs 31.8%; p <0.0001) and uninsured/self-pay (18.6% vs 10.1%; p <0.0001) were more prevalent in patients with H. pylori infection.

Factors associated with H. pylori infection in patients with PUD and concurrent cirrhosis

Several predictors associated with H. pylori infection among patients with PUD and concurrent cirrhosis are African American (OR 2.3, 95% CI: 1.5-3.6), Hispanic (OR 2.6, 95% CI: 1.7-4.0), and smoking (OR 1.5, 95% CI: 1.1-2.2).


Several significant findings of the present study include the following: (1) H. pylori were significantly associated with PUD in cirrhotic patients, (2) the prevalence of H. pylori among patients admitted with PUD and concurrent cirrhosis was lower than the general population, (3) African American, Hispanic, and smoking were significant factors associated with increased odds of H. pylori infection.

The prevalence of H. pylori infection varies with different geographic locations around the world. It ranges from 50%-70% in Asian countries to 15.5% in an Australian study of mainly white population. 18 In a meta-analysis by Hooi et al., the pooled H. pylori prevalence estimate for the United States (US) general population was 35.6%. 19 Compared to our findings, previous studies have suggested a higher prevalence of H. pylori infection in cirrhotic patients compared to the general population.

However, the results varied with the method of diagnosis (serological versus endoscopic diagnosis). 20,21 A meta-analysis by Vergara in 2002 suggested a high prevalence of H. pylori infection without PUD in cirrhotic populations. 22 Asymptomatic H. pylori infection might contribute to low prevalence in the present study because the majority of H. pylori infections could have been underdiagnosed. This postulate is supported by a Greek study of asymptomatic patients with cirrhosis undergoing screening endoscopy.

The study did not find an association between H. pylori infection and PUD in cirrhotic patient. 5 Congestive gastropathy from portal hypertension in liver cirrhosis resulting in a hostile environment for H. pylori might be contributory. 23,24 Furthermore, a study by Kim et al. suggested that the severity of liver cirrhosis is inversely related to the presence of H. pylori infection. 25

H. pylori are well known to cause PUD, chronic gastritis, gastric cancer, and gastric mucosaassociated lymphoid tissue lymphoma. Their pathogenic role in liver cirrhosis is not exactly clear. Nonetheless, our results suggested that their presence is more likely to be associated with complicated hospitalizations in the studied population (51.2% vs 44.2%; p <0.0067). This finding is contradictory to previous studies, which suggested that H. pylori may not play a role in cirrhotic patients with PUD. 23,24,26 Although the prevalence may be low especially in decompensated cirrhotic patients, the infection is more likely to be associated with follicular gastritis and gastric variceal bleeding.

Different types of gastritis from H. pylori infection, such as atrophic versus follicular types, can explain the inconsistency in our results. Atrophic type causes low gastric acid secretions due to atrophied parietal cells, whereas follicular type causes increased gastric acid secretions by stimulating gastrin secretion from G cells. H. pyloriinduced follicular gastritis can be considered as an independent risk factor for gastric variceal bleeding, which can result in complicated hospital admissions. 27 However, it is not exactly clear which type is predominant in PUD patients with cirrhosis.

H. pylori infection was more common in middle-aged, African American, or Hispanic, male patients compared to those without the infection according to our study. According to our literature search, we did not notice a similar epidemiologic study in the US population that evaluated the association of H. pylori infection with PUD in cirrhotic patients. However, a large histo-epidemiological study by Sonnenberg et al. suggested that H. pylori infection is more common in males and low socioeconomic populations. 28

A serological study of H. pylori in low-income individuals in the southeastern United States by Epplein et al. suggested that African Americans had two- to six-fold increased odds of H. pylori seropositivity after adjusting socioeconomic status. 29 In addition, a singlecenter histopathological study by Nguyen et al. mentioned the highest risk of H. pylori infection among African American and Hispanic populations. 30 In line with previous studies, the present study suggested that being African American or Hispanic increases the odds of H. pylori infection by 2.3- and 2.6-folds, respectively. Risk factors contributing to H. pylori infection in the studied population could have been similar to the general population hence explaining our results.

It is well known that alcohol and smoking are related to PUD, whereas their relationship to H. pylori infection is not exactly clear. In the present study, smoking increases the odds of H. pylori infection by one-and-half folds (OR 1.5, 95% CI: 1.1-2.2, p <0.001). This is in contrast to one Chinese and two Japanese studies that reported a negative association between smoking and H. pylori infection. 31-33 On the contrary, a study from Northern Ireland reported a positive correlation, whereas other studies reported no association between smoking and H. pylori infection. 34-36 The only Asian study that suggested a positive correlation was a singer center Japanese study that included outpatient male smoking patients. 37

The genetics, racial, and lifestyle differences may explain the discrepancy because the majority of our studied population was white and more closely resembled the Northern Ireland study. Unfortunately, our study was not designed to evaluate the difference in those results. Several studies in different parts of the world have mentioned a negative correlation between alcohol and H. pylori infection. 31,34,38-41 Alcohol may exert antimicrobial effects on H. pylori, inhibit growth by lowering gastric pH, and affect gastric acid secretion, gastric mucosa, and gastric emptying both directly and indirectly thereby creating a hostile environment for H. pylori colonization. 42-47 We did not find a statistically significant association between alcohol and H. pylori infection in our studied population (OR 1, 95% CI: 0.7-1.5), so conclusions cannot be made.

Low socioeconomic status is an independent risk factor for H. pylori infection, and this probably remains the same for PUD and cirrhotic patients. As mentioned in our results, factors associated with low socioeconomic status such as low median household income, uninsured/self-pay were significantly associated with H. pylori infection. Other risk factors include dietary habits and lifestyle behaviours. Underlying medical comorbidities such as obesity, hypertension, congestive heart failure, and chronic pulmonary disease, etc., cannot predict H. pylori infection in the studied population. H. pylori are supposedly acquired in the early phase of life; hence its prevalence is likely not affected by medical comorbidities. 48

Our study is the first nationwide study looking at H. pylori epidemiology in hospitalized patients with PUD and cirrhosis. Since our results relied on accurate coding practices across the nation, the acquired data could have been confounded and will need to be interpreted with caution. We only studied hospitalized patients, so our results will not be applicable to the general outpatient population. We did not evaluate causation and explanation of our findings, owing to the retrospective nature of our study. Despite the limitations, strengths of our study include a large sample size representative of the general US population and the first nationwide study on this particular subject.


Finally, we concluded that H. pylori are associated with PUD and concurrent cirrhosis. However, it is less prevalent than other studies done in the general population. African American, Hispanic, and smoking were significant factors that increased the odds of H. pylori infection. Our results suggested that future large-scale studies are required to further understand the epidemiology and confirm our findings.

References available on request

If you would like to receive an HPN magazine every month, complete the form below to be added to the mailing list. Only those who meet the expected criteria for readership will be added to the list. SUBSCRIBE

Follow us:

Leave a Reply

Your email address will not be published. Required fields are marked *

Please Confirm

This website is only for the eyes of medical professionals. Are you a medical professional?